Engro Polymer and Chemicals Limited (PSX:EPCL)

CTI BioPharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,404	33,694	42,347	38,466	49,273	43,183
Market Cap Growth	-16.63%	-20.43%	10.09%	-21.93%	14.10%	43.06%
Enterprise Value	67,859	73,036	61,916	53,848	52,961	60,477
Last Close Price	29.05	37.07	45.53	34.84	35.45	25.31
PE Ratio	-	-	5.11	3.42	3.33	7.54
Forward PE	193.67	14.97	5.83	3.77	4.92	8.21
PS Ratio	0.33	0.45	0.52	0.47	0.70	1.22
PB Ratio	1.10	1.23	1.48	1.42	1.64	1.65
P/TBV Ratio	1.28	1.42	1.70	1.64	1.88	1.88
P/FCF Ratio	21.68	-	-	3.04	4.52	10.70
P/OCF Ratio	4.02	4.85	8.21	1.77	3.46	3.86
EV/Sales Ratio	0.86	0.97	0.76	0.66	0.76	1.71
EV/EBITDA Ratio	15.08	12.29	3.02	2.37	2.29	5.60
EV/EBIT Ratio	28.05	19.01	3.53	2.65	2.49	6.36
EV/FCF Ratio	55.72	-	-	4.26	4.86	14.99
Debt / Equity Ratio	1.76	1.59	1.23	1.07	0.86	1.01
Debt / EBITDA Ratio	7.08	6.72	1.68	1.24	1.09	2.34
Debt / FCF Ratio	-	-	-	2.29	2.36	6.52
Asset Turnover	0.79	0.79	0.92	1.00	0.95	0.56
Inventory Turnover	3.49	3.49	3.66	4.24	4.06	3.48
Quick Ratio	0.28	0.46	0.40	0.68	0.76	1.05
Current Ratio	0.87	0.95	1.02	1.10	1.39	1.58
Return on Equity (ROE)	-0.32%	-0.57%	32.06%	40.95%	53.70%	26.10%
Return on Assets (ROA)	2.67%	2.51%	12.46%	15.54%	18.11%	9.39%
Return on Capital (ROIC)	3.81%	3.56%	18.28%	22.71%	24.62%	12.22%
Return on Capital Employed (ROCE)	7.30%	6.40%	31.10%	38.90%	39.60%	17.70%
Earnings Yield	-7.58%	-0.48%	21.09%	30.39%	30.57%	13.27%
FCF Yield	4.61%	-6.62%	-14.67%	32.86%	22.14%	9.34%
Dividend Yield	-	-	13.18%	35.88%	45.98%	4.93%
Payout Ratio	-	-	88.79%	123.11%	67.81%	3.23%
Buyback Yield / Dilution	13.17%	24.82%	-	-	-31.46%	-1.17%
Total Shareholder Return	-	24.82%	13.18%	35.88%	14.52%	3.75%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.